Burkett Financial Services’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2,821
Closed -$41.2K – 381
2026
Q2
$41.2K Hold
2,821
– – 0.01% 113
2026
Q1
$20.9K Hold
2,821
– – 0.01% 144
2025
Q4
$33.2K Hold
2,821
– – 0.01% 119
2025
Q3
$21.8K Hold
2,821
– – 0.01% 135
2025
Q2
$20.6K Hold
2,821
– – 0.01% 125
2025
Q1
$26.8K Hold
2,821
– – 0.01% 118
2024
Q4
$46.5K Hold
2,821
– – 0.02% 89
2024
Q3
$41.6K Hold
2,821
– – 0.02% 88
2024
Q2
$39.1K Hold
2,821
– – 0.02% 86
2024
Q1
$44.3K Hold
2,821
– – 0.02% 88
2023
Q4
$45.6K Buy
+2,821
New +$46.2K 0.03% 86

Other funds holding NEO

Burkett Financial Services's NEO Position: Q3 2026 in Review

Burkett Financial Services sold out of NeoGenomics (NEO) in Q3 2026, closing a stake of 2,821 shares — an estimated $41.2K sold.

Burkett Financial Services first reported a position in NEO in Q4 2023 and held it in 11 quarters. The position peaked at $46.5K in Q4 2024. 9 funds tracked by Wall St. Rank hold NEO as of Q3 2026.

  • Burkett Financial Services reported no remaining NeoGenomics position as of Q3 2026 after selling out during the quarter.
  • Burkett Financial Services sold 2,821 NeoGenomics shares in Q3 2026, an estimated $41.2K.
  • Burkett Financial Services first reported a position in NeoGenomics in Q4 2023 and held it in 11 quarters.
  • Burkett Financial Services's NeoGenomics position peaked at $46.5K in Q4 2024.
  • 9 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2026.

Based on Burkett Financial Services's 13F filing for Q3 2026, filed 1 Oct 2026.